Citation Tools

Download PDFPDF

Original research
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors

Download to a citation manager

Cite this article as:
Taylor K, Loo Yau H, Chakravarthy A, et al
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors